{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T16:59:08Z","timestamp":1769705948153,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,28]]},"DOI":"10.7759\/cureus.102520","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T05:56:05Z","timestamp":1769666165000},"source":"Crossref","is-referenced-by-count":0,"title":["Multispecies Probiotic Supplementation in Chronic Kidney Disease (CKD): Insights From Indian Nephrology Experts"],"prefix":"10.7759","author":[{"given":"Pankaj","family":"Beniwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Singla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deba Prasad","family":"Kar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinant","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naman","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DK","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Ruhela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rathan","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishnu","family":"RS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Bhosle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kapil","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarita","family":"Bajpai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.88","article-title":"Chronic kidney disease","volume":"3","author":"Romagnani P","year":"2017","unstructured":"Romagnani P, Remuzzi G, Glassock R, et al.. Chronic kidney disease. Nat Rev Dis Primers. 2017, 3:17088. 10.1038\/nrdp.2017.88","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13040252","article-title":"The impact of CKD on uremic toxins and gut microbiota","volume":"13","author":"Rysz J","year":"2021","unstructured":"Rysz J, Franczyk B, \u0141awi\u0144ski J, Olszewski R, Cia\u0142kowska-Rysz A, Gluba-Brz\u00f3zka A. The impact of CKD on uremic toxins and gut microbiota. Toxins (Basel). 2021, 13:252. 10.3390\/toxins13040252","journal-title":"Toxins (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000360010","article-title":"Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD","volume":"39","author":"Wong J","year":"2014","unstructured":"Wong J, Piceno YM, DeSantis TZ, Pahl M, Andersen GL, Vaziri ND. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol. 2014, 39:230-7. 10.1159\/000360010","journal-title":"Am J Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013080905","article-title":"The gut microbiome, kidney disease, and targeted interventions","volume":"25","author":"Ramezani A","year":"2014","unstructured":"Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol. 2014, 25:657-70. 10.1681\/ASN.2013080905","journal-title":"J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000345969","article-title":"Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease","volume":"37","author":"Vaziri ND","year":"2013","unstructured":"Vaziri ND, Yuan J, Norris K. Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease. Am J Nephrol. 2013, 37:1-6. 10.1159\/000345969","journal-title":"Am J Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000353764","article-title":"Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction","volume":"38","author":"Vaziri ND","year":"2013","unstructured":"Vaziri ND, Yuan J, Nazertehrani S, Ni Z, Liu S. Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction. Am J Nephrol. 2013, 38:99-103. 10.1159\/000353764","journal-title":"Am J Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-003-0381-7","article-title":"Bacterial translocation in experimental uremia","volume":"32","author":"de Almeida Duarte JB","year":"2004","unstructured":"de Almeida Duarte JB, de Aguilar-Nascimento JE, Nascimento M, Nochi RJ Jr. Bacterial translocation in experimental uremia. Urol Res. 2004, 32:266-70. 10.1007\/s00240-003-0381-7","journal-title":"Urol Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.040618-0","article-title":"Long-term impacts of antibiotic exposure on the human intestinal microbiota","volume":"156","author":"Jernberg C","year":"2010","unstructured":"Jernberg C, L\u00f6fmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology. 2010, 156:3216-23. 10.1099\/mic.0.040618-0","journal-title":"Microbiology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/nu14194044","article-title":"The potential benefits and controversies of probiotics use in patients at different stages of chronic kidney disease","volume":"14","author":"Tian N","year":"2022","unstructured":"Tian N, Li L, Ng JK, Li PK. The potential benefits and controversies of probiotics use in patients at different stages of chronic kidney disease. Nutrients. 2022, 14:4044. 10.3390\/nu14194044","journal-title":"Nutrients"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.255","article-title":"Probiotics and chronic kidney disease","volume":"88","author":"Koppe L","year":"2015","unstructured":"Koppe L, Mafra D, Fouque D. Probiotics and chronic kidney disease. Kidney Int. 2015, 88:958-66. 10.1038\/ki.2015.255","journal-title":"Kidney Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfac056","article-title":"Probiotics for kidney disease","volume":"15","author":"Favero C","year":"2022","unstructured":"Favero C, Ortiz A, Sanchez-Ni\u00f1o MD. Probiotics for kidney disease. Clin Kidney J. 2022, 15:1981-6. 10.1093\/ckj\/sfac056","journal-title":"Clin Kidney J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903069249","article-title":"Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada","volume":"25","author":"Ranganathan N","year":"2009","unstructured":"Ranganathan N, Friedman EA, Tam P, Rao V, Ranganathan P, Dheer R. Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada. Curr Med Res Opin. 2009, 25:1919-30. 10.1185\/03007990903069249","journal-title":"Curr Med Res Opin"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-010-0059-9","article-title":"Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease","volume":"27","author":"Ranganathan N","year":"2010","unstructured":"Ranganathan N, Ranganathan P, Friedman EA, et al.. Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv Ther. 2010, 27:634-47. 10.1007\/s12325-010-0059-9","journal-title":"Adv Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2014.05.006. 10.1053\/ajkd.2003.50104","article-title":"Effects of a symbiotic on gut microbiota in Mexican patients with end-stage renal disease","volume":"24","author":"Cruz-Mora J","year":"2014","unstructured":"Cruz-Mora J, Mart\u00ednez-Hern\u00e1ndez NE, Mart\u00edn Del Campo-L\u00f3pez F, et al.. Effects of a symbiotic on gut microbiota in Mexican patients with end-stage renal disease. J Ren Nutr. 2014, 24:330-5. 10.1053\/j.jrn.2014.05.006. 10.1053\/ajkd.2003.50104","journal-title":"J Ren Nutr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2003.50104","article-title":"Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis","volume":"41","author":"Takayama F","year":"2003","unstructured":"Takayama F, Taki K, Niwa T. Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis. Am J Kidney Dis. 2003, 41:S142-5. 10.1053\/ajkd.2003.50104","journal-title":"Am J Kidney Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.67987","article-title":"The efficacy and safety of probiotic combinations Lobun Forte\u00ae versus Renadyl\u00ae in patients with chronic kidney disease: a comparative, phase IV, randomized, open-label, active-controlled, parallel study","volume":"16","author":"Kalidindi RK","year":"2024","unstructured":"Kalidindi RK, Reddy CP, Pv K, Kompella P. The efficacy and safety of probiotic combinations Lobun Forte\u00ae versus Renadyl\u00ae in patients with chronic kidney disease: a comparative, phase IV, randomized, open-label, active-controlled, parallel study. Cureus. 2024, 16:e67987. 10.7759\/cureus.67987","journal-title":"Cureus"},{"key":"ref17","article-title":"MO563: Effect of probiotics on uremic toxins production and inflammation in patients suffering from CKD stage 3 and 4","volume":"3","author":"Sharma M","year":"2022","unstructured":"Sharma M, Kharbuli I, Kumar Doley P, et al.. MO563: Effect of probiotics on uremic toxins production and inflammation in patients suffering from CKD stage 3 and 4. Nephrol Dial Transplant. 2022, 3:gfac074-008.","journal-title":"Nephrol Dial Transplant"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1159\/000494677","article-title":"Efficacy of probiotics supplementation on chronic kidney disease: a systematic review and meta-analysis","volume":"43","author":"Jia L","year":"2018","unstructured":"Jia L, Jia Q, Yang J, Jia R, Zhang H. Efficacy of probiotics supplementation on chronic kidney disease: a systematic review and meta-analysis. Kidney Blood Press Res. 2018, 43:1623-35. 10.1159\/000494677","journal-title":"Kidney Blood Press Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13050334","article-title":"An innovative synbiotic formulation decreases free serum indoxyl sulfate, small intestine permeability and ameliorates gastrointestinal symptoms in a randomized pilot trial in stage IIIb-IV CKD patients","volume":"13","author":"Cosola C","year":"2021","unstructured":"Cosola C, Rocchetti MT, di Bari I, et al.. An innovative synbiotic formulation decreases free serum indoxyl sulfate, small intestine permeability and ameliorates gastrointestinal symptoms in a randomized pilot trial in stage IIIb-IV CKD patients. Toxins (Basel). 2021, 13:334. 10.3390\/toxins13050334","journal-title":"Toxins (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.1c01547","article-title":"Preventive effects of Lactobacillus mixture against chronic kidney disease progression through enhancement of beneficial bacteria and downregulation of gut-derived uremic toxins","volume":"69","author":"Huang H","year":"2021","unstructured":"Huang H, Li K, Lee Y, Chen M. Preventive effects of Lactobacillus mixture against chronic kidney disease progression through enhancement of beneficial bacteria and downregulation of gut-derived uremic toxins. J Agric Food Chem. 2021, 69:7353-66. 10.1021\/acs.jafc.1c01547","journal-title":"J Agric Food Chem"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1590\/2175-8239-JBN-2022-0021en","article-title":"Use of probiotics in patients with chronic kidney disease on hemodialysis: a randomized clinical trial","volume":"45","author":"de Ara\u00fajo \u00c9MR","year":"2023","unstructured":"de Ara\u00fajo \u00c9MR, Meneses GC, Carioca AA, Martins AM, Daher EF, Silva Junior GB. Use of probiotics in patients with chronic kidney disease on hemodialysis: a randomized clinical trial. J Bras Nefrol. 2023, 45:152-61. 10.1590\/2175-8239-JBN-2022-0021en","journal-title":"J Bras Nefrol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3920\/BM2014.0088","article-title":"The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial","volume":"6","author":"Wang IK","year":"2015","unstructured":"Wang IK, Wu YY, Yang YF, et al.. The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial. Benef Microbes. 2015, 6:423-30. 10.3920\/BM2014.0088","journal-title":"Benef Microbes"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.23876\/j.krcp.21.014","article-title":"The effect of probiotic supplementation on systemic inflammation in dialysis patients","volume":"41","author":"Choi E","year":"2022","unstructured":"Choi E, Yang J, Ji GE, et al.. The effect of probiotic supplementation on systemic inflammation in dialysis patients. Kidney Res Clin Pract. 2022, 41:89-101. 10.23876\/j.krcp.21.014","journal-title":"Kidney Res Clin Pract"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/568571","article-title":"Randomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patients","volume":"2014","author":"Natarajan R","year":"2014","unstructured":"Natarajan R, Pechenyak B, Vyas U, et al.. Randomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patients. Biomed Res Int. 2014, 2014:568571. 10.1155\/2014\/568571","journal-title":"Biomed Res Int"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-018-1831-x","article-title":"Correction to: An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD)","volume":"58","author":"Simeoni M","year":"2019","unstructured":"Simeoni M, Citraro ML, Cerantonio A, et al.. Correction to: An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD). Eur J Nutr. 2019, 58:2157. 10.1007\/s00394-018-1831-x","journal-title":"Eur J Nutr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05240515","article-title":"Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial","volume":"11","author":"Rossi M","year":"2016","unstructured":"Rossi M, Johnson DW, Morrison M, et al.. Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial. Clin J Am Soc Nephrol. 2016, 11:223-31. 10.2215\/CJN.05240515","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq624","article-title":"Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study","volume":"26","author":"Nakabayashi I","year":"2011","unstructured":"Nakabayashi I, Nakamura M, Kawakami K, Ohta T, Kato I, Uchida K, Yoshida M. Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. Nephrol Dial Transplant. 2011, 26:1094-8. 10.1093\/ndt\/gfq624","journal-title":"Nephrol Dial Transplant"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2014.04.007","article-title":"Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: a randomized clinical trial","volume":"24","author":"Guida B","year":"2014","unstructured":"Guida B, German\u00f2 R, Trio R, et al.. Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: a randomized clinical trial. Nutr Metab Cardiovasc Dis. 2014, 24:1043-9. 10.1016\/j.numecd.2014.04.007","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3305\/nh.2014.29.3.7179","article-title":"Effect of probiotics on human blood urea levels in patients with chronic renal failure","volume":"29","author":"Miranda Alatriste PV","year":"2014","unstructured":"Miranda Alatriste PV, Urbina Arronte R, G\u00f3mez Espinosa CO, Espinosa Cuevas MD. Effect of probiotics on human blood urea levels in patients with chronic renal failure. Nutr Hosp. 2014, 29:582-90. 10.3305\/nh.2014.29.3.7179","journal-title":"Nutr Hosp"},{"key":"ref30","article-title":"Influence of prebiotic and probiotic supplementation on the progression of chronic kidney disease","volume":"68","author":"Pavan M","year":"2016","unstructured":"Pavan M. Influence of prebiotic and probiotic supplementation on the progression of chronic kidney disease. Minerva Urol Nefrol. 2016, 68:222-6.","journal-title":"Minerva Urol Nefrol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2022.07.008","article-title":"The impact of synbiotic treatment on the levels of gut-derived uremic toxins, inflammation, and gut microbiome of chronic kidney disease patients-a randomized trial","volume":"33","author":"Mitrovi\u0107 M","year":"2023","unstructured":"Mitrovi\u0107 M, Stankovi\u0107-Popovi\u0107 V, Tolina\u010dki M, et al.. The impact of synbiotic treatment on the levels of gut-derived uremic toxins, inflammation, and gut microbiome of chronic kidney disease patients-a randomized trial. J Ren Nutr. 2023, 33:278-88. 10.1053\/j.jrn.2022.07.008","journal-title":"J Ren Nutr"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Kidney disease: Improving Global Outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Stevens PE","year":"2013","unstructured":"Stevens PE, Levin A. Kidney disease: Improving Global Outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013, 3:1-150. 10.7326\/0003-4819-158-11-201306040-00007","journal-title":"Kidney Int Suppl"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1186\/s12906-015-0952-5","article-title":"Effect of microbial cell preparation on renal profile and liver function among type 2 diabetics: a randomized controlled trial","volume":"15","author":"Firouzi S","year":"2015","unstructured":"Firouzi S, Mohd-Yusof BN, Majid HA, et al.. Effect of microbial cell preparation on renal profile and liver function among type 2 diabetics: a randomized controlled trial. BMC Complement Altern Med. 2015, 15:433.","journal-title":"BMC Complement Altern Med"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.1016\/S0020-2452(98)80011-0","article-title":"Potential hazards of probiotic bacteria for immunodeficient patients","volume":"96","author":"Wagner RD","year":"1998","unstructured":"Wagner RD, Balish E. Potential hazards of probiotic bacteria for immunodeficient patients. Bull Inst Pasteur. 1998, 96:165-70.","journal-title":"Bull Inst Pasteur"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2023.08.011","article-title":"A pilot study of nephrogenic probiotics to further improve an already stabilized graft function after kidney transplantation","volume":"55","author":"Chan WN","year":"2023","unstructured":"Chan WN, Ho DR, Huang YC, Lin JH, Liu YL, Chen MJ, Chen CS. A pilot study of nephrogenic probiotics to further improve an already stabilized graft function after kidney transplantation. Transplant Proc. 2023, 55:2090-4. 10.1016\/j.transproceed.2023.08.011","journal-title":"Transplant Proc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/423918-multispecies-probiotic-supplementation-in-chronic-kidney-disease-ckd-insights-from-indian-nephrology-experts","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T05:56:06Z","timestamp":1769666166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/423918-multispecies-probiotic-supplementation-in-chronic-kidney-disease-ckd-insights-from-indian-nephrology-experts"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.102520","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,28]]}}}